Eruptive melanocytic naevi following melanotan injection

British Journal of Dermatology

Volumn 161, Issue 3, 2009, Pages 707-708

  Cousen, P ^a   Colver, G ^a   Helbling, I ^a  

^a CHESTERFIELD ROYAL HOSPITAL   (United Kingdom)

Author keywords

Melanotan; Naevi

Indexed keywords

MELANOTAN II;

ADULT; CASE REPORT; DRUG ERUPTION; FEMALE; HUMAN; HYPERPIGMENTATION; LETTER; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; SKIN PIGMENTATION;

ADULT; ALPHA-MSH; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; NEVUS, PIGMENTED; PEPTIDES, CYCLIC; RECEPTORS, MELANOCORTIN; SKIN NEOPLASMS; YOUNG ADULT;

EID: 69149098959     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09362.x     Document Type: Letter

References (6)

1. Evans-Brown M, Dawson RT, Chandler M, McVeigh J. Use of melanotan I and II in the general population. BMJ 2009 338 : b566.
2. Langan EA, Ramlogan D, Jamieson LA, Rhodes LE. Change in moles linked to use of unlicensed 'sun tan jab'. BMJ 2009 338 : b277.
3. Ellis R, Kirkham N, Seukeran D. Malignant melanoma in a user of melanotan I. BMJ 2009 Rapid responses.
4. Melanotan.org. 2009. Available at: http://melanotan.org/ (last accessed 16 May 2009).
5. Gelfer A, Rivers JK. Long-term follow-up of a patient with eruptive melanocytic nevi after Stevens-Johnson syndrome. Arch Dermatol 2007 143 : 1555 1557.
6. Cardones AR, Grichnik JM. α-Melanocyte-stimulating hormone-induced eruptive nevi. Arch Dermatol 2009 145 : 441 444.